BrightSpring Health Services Inc has a consensus price target of $15.85 based on the ratings of 12 analysis. The 3 most-recent analyst ratings were released by BTIG, Wells Fargo, and HSBC on June 21, 2024, May 6, 2024, and March 6, 2024, respectively. With an average price target of $14.67 between BTIG, Wells Fargo, and HSBC, there's an implied 32.85% upside for BrightSpring Health Services Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/21/2024 | Buy Now | 35.87% | BTIG | David Larsen | → $15 | Initiates | → Buy | Get Alert |
05/06/2024 | Buy Now | 44.93% | Wells Fargo | Stephen Baxter | $15 → $16 | Maintains | Overweight | Get Alert |
03/06/2024 | Buy Now | 17.75% | HSBC | Sidharth Sahoo | → $13 | Initiates | → Buy | Get Alert |
03/04/2024 | Buy Now | 108.33% | Goldman Sachs | Jamie Perse | $26 → $23 | Maintains | Buy | Get Alert |
02/20/2024 | Buy Now | 4.17% | Deutsche Bank | Pito Chickering | → $11.5 | Initiates | → Hold | Get Alert |
02/20/2024 | Buy Now | 35.87% | Leerink Partners | Whit Mayo | → $15 | Initiates | → Outperform | Get Alert |
02/20/2024 | Buy Now | 26.81% | B of A Securities | Joanna Gajuk | → $14 | Initiates | → Buy | Get Alert |
02/20/2024 | Buy Now | 35.87% | UBS | A.J. Rice | → $15 | Initiates | → Buy | Get Alert |
02/20/2024 | Buy Now | 35.87% | Wells Fargo | Stephen Baxter | → $15 | Initiates | → Overweight | Get Alert |
02/20/2024 | Buy Now | 63.04% | Jefferies | Brian Tanquilut | → $18 | Initiates | → Buy | Get Alert |
02/20/2024 | Buy Now | 63.04% | Morgan Stanley | Erin Wright | → $18 | Initiates | → Overweight | Get Alert |
02/20/2024 | Buy Now | 135.51% | Goldman Sachs | Jamie Perse | → $26 | Initiates | → Buy | Get Alert |
The latest price target for BrightSpring Health (NASDAQ:BTSG) was reported by BTIG on June 21, 2024. The analyst firm set a price target for $15.00 expecting BTSG to rise to within 12 months (a possible 35.87% upside). 12 analyst firms have reported ratings in the last year.
The latest analyst rating for BrightSpring Health (NASDAQ:BTSG) was provided by BTIG, and BrightSpring Health initiated their buy rating.
There is no last upgrade for BrightSpring Health
There is no last downgrade for BrightSpring Health.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrightSpring Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrightSpring Health was filed on June 21, 2024 so you should expect the next rating to be made available sometime around June 21, 2025.
While ratings are subjective and will change, the latest BrightSpring Health (BTSG) rating was a initiated with a price target of $0.00 to $15.00. The current price BrightSpring Health (BTSG) is trading at is $11.04, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.